Notable Labs’ mission is to change the way cancer is treated, which starts with putting patients first. The company is developing a personalized treatment service for cancer patients that will prioritize combinations of FDA-approved treatments that can be immediately prescribed by a doctor. Focusing on individual patients and existing treatments, the company is discovering novel uses of drugs and defining mechanisms underlying development of cancer progression and drug resistance. Using modern data science and robotics, Notable Labs is building a scalable, iterative model with the ultimate aim of turning treatment selection into a data problem. Headquartered in San Francisco, California, the company is currently partnering with clinicians at several research hospitals in the United States and Canada to identify promising, actionable treatments for relapsed and refractory acute leukemia patients.